Skip to content
Review

Artificial intelligence analysis of the electrocardiogram for early identification of cancer therapy related cardiotoxicity: a systematic review and meta-analysis

Aug 2026 · European Heart Journal, Supplement · Vol 28 · 0 citations

TL;DR

Artificial intelligence-enabled ECG analysis demonstrates encouraging overall diagnostic accuracy for early identification of CTRCD, with high specificity and NPV, and larger studies are needed to clarify the role of AI-ECG as a complementary tool within cardio-oncology surveillance strategies.

Abstract

Cancer therapy-related cardiac dysfunction (CTRCD) is a common, often subclinical complication of cancer treatment, and current imaging-based surveillance is resource-intensive. Artificial intelligence (AI)-enabled ECG analysis offers a scalable approach for early cardiotoxicity risk prediction, but supporting evidence remains unsynthesized. To evaluate the pooled sensitivity, specificity, and predictive value of AI-enabled ECG for early CTRCD identification through a systematic review and meta-analysis PubMed, Embase, and Cochrane Central were searched for AI-based ECG studies on early CTRCD detection. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were pooled using random-effects models, with 95% of confidence interval (CI). Performance summarized using a summary receiver operating characteristic (SROC) curve and area under the curve (AUC) via parametric bootstrapping. Three studies comprising 5,153 anthracycline-treated patients were included, 66.2% female with a mean age 60.7 years. Mean follow-up ranging from 1.5 to 9.5 years. AI-based ECG analysis showed a pooled sensitivity of 82.1% (95% CI, 58.0-93.9%) and specificity of 87.7% (95% CI, 82.5-91.4%). The pooled NPV was 99% (95% CI, 98-99.5%), whereas the pooled PPV was 22.4% (95% CI, 8.7-46.7%). Diagnostic performance was favorable, with an SROC AUC of 0.91 (95% CI, 0.75-0.96). AI-enabled ECG analysis demonstrates encouraging overall diagnostic accuracy for early identification of CTRCD, with high specificity and NPV. Larger studies are needed to validate these results and to clarify the role of AI-ECG as a complementary tool within cardio-oncology surveillance strategies.Graphical abstract  SROC curve

View source

Similar papers

Review Open access Sep 2026

Diagnostic performance of artificial intelligence–enabled electrocardiography for pulmonary hypertension: a systematic review and meta-analysis

Abstract Pulmonary hypertension (PH) is a progressive, under-recognized condition with substantial morbidity and mortality. Its non-specific presentation and multimodal diagnostic pathway contribute to delayed diagnosis. Artificial intelligence (AI)-enabled electrocardiography (ECG) may offer a scalable approach to cas...

K. R. Nazareth, E. Jamileh, Fahad Muhammad et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence-Enabled Electrocardiograms and Pregnancy-Related Cardiomyopathy: A Systematic Review and Diagnostic Meta-Analysis.

BACKGROUND Pregnancy-related cardiomyopathy (PRCM) is a leading cause of maternal death in the United States. PRCM symptoms often overlap with those of normal pregnancy and the lack of validated screening tools limits early recognition and contributes to diagnostic delays. Multiple artificial intelligence-enabled elect...

O. Adesanya, Osaivbie E. Irorere, K. Young et al. · 0 citations
Review Open access Aug 2026

Artificial intelligence in electrocardiogram interpretation for cardiovascular diagnosis and risk prediction: a systematic review of evidence through May 2026

Artificial intelligence-enabled electrocardiogram interpretation shows strongest support for arrhythmia detection and automated ECG classification, while structural disease screening and prognostic modeling remain promising but less mature.

Mohamed Elhussain, Esra M. Abdalla, Ragda Ali et al. · 0 citations
Review Open access Aug 2026

Artificial intelligence–enabled electrocardiography for detection of left ventricular diastolic dysfunction: a systematic review and meta-analysis

Artificial intelligence-enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations, however, current evidence remains insufficient to support routine clinical implementation.

Johann A. C. Edjimbi, Nisarg Shah, L. Donisi et al. · 1 citation
Review Open access Sep 2026

Diagnostic Accuracy of Artificial Intelligence-Based Electrocardiography for the Detection of Heart Diseases: A Systematic Review and Meta-Analysis

For HF/LVSD, AI-ECG shows consistent and reproducible accuracy against echocardiography, and this estimate proved robust to the exclusion of studies at high risk of bias.

J. J. Barboza, Óscar Andrés Ramírez-Terán, E. Tomás-Alvarado et al. · 0 citations
Review Open access Sep 2026

A systematic review on cardiovascular risk stratification in the artificial intelligence paradigm using radiogenomics

Background: The cardiovascular risk and patient management are evaluated on the basis of risk scores that account for the multifactorial risk factors and thus fail in the estimation of an individual’s cardiovascular disease (CVD) risk. Advances in the field of medical imaging, especially cardiac computed tomography ang...

Manasvi Singh, N. Khanna, A. Nicolaides et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.